Jade Biosciences, Inc. Common Stock (NASDAQ: JBIO) last traded at $14.03, down 2.54% on the session. The quote above updates while this page is open; the figures below are drawn from Jade Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Jade Biosciences, Inc. Common Stock trades on NASDAQ under the ticker JBIO. Its market capitalisation is $891.95 million.
Valuation measures for Jade Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $891.95M |
|---|---|
| Enterprise value | $816.90M |
| Price / book | 2.03 |
| Beta | 1.28 |
Trailing-twelve-month figures tagged in Jade Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$153.24M |
| Return on equity | -34.83% |
|---|
| Cash | $107.25M |
|---|
Range and volume for JBIO over the past 52 weeks.
| 52-week high | $28.00 |
|---|---|
| 52-week low | $8.36 |
| Volume | 670.7K |
| Average volume | 890.6K |
| Previous close | $14.39 |
Invest a chosen dollar amount in Jade Biosciences, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell JBIO.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.